Cargando…
A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario
People have continued to be petrified by the devastating effects of cancer for decades and thus a pursuit for developing anticancer agents have seen an ever-increasing trend in the past few decades. Globally, breast cancer is the most common malignancy in women and the second most common cause of ca...
Autores principales: | Nahvi, Insha, Belkahla, Sana, Biswas, Supratim, Chakraborty, Suparna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356294/ https://www.ncbi.nlm.nih.gov/pubmed/35941873 http://dx.doi.org/10.3389/fonc.2022.953865 |
Ejemplares similares
-
Advances and development of prostate cancer, treatment, and strategies: A systemic review
por: Belkahla, Sana, et al.
Publicado: (2022) -
Cascade Release Nanocarriers for the Triple-Negative Breast Cancer Near-Infrared Imaging and Photothermal-Chemo Synergistic Therapy
por: Li, Ke, et al.
Publicado: (2021) -
Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2021) -
Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
por: Fatima, Mahak, et al.
Publicado: (2022) -
Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
por: Chakrabarty, Anindita, et al.
Publicado: (2021)